NasdaqCM - Delayed Quote USD
Biodexa Pharmaceuticals Plc (BDRX)
1.1500
+0.0700
+(6.48%)
At close: June 2 at 4:00:02 PM EDT
1.2000
+0.05
+(4.35%)
Pre-Market: 5:01:25 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-12,261
-12,261
-6,826
-7,048
-6,008
Investing Cash Flow
-598
-598
-265
-220
-278
Financing Cash Flow
8,557
8,557
10,226
47
8,805
End Cash Position
1,669
1,669
5,971
2,836
10,057
Capital Expenditure
-774
-774
-263
-62
-320
Issuance of Capital Stock
8,312
8,312
10,427
243
9,035
Issuance of Debt
431
431
0
0
0
Repayment of Debt
-186
-186
-188
-178
-215
Free Cash Flow
-13,035
-13,035
-7,089
-7,110
-6,328
12/31/2021 - 12/7/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZVSA ZyVersa Therapeutics, Inc.
0.6563
+4.37%
ENTO Entero Therapeutics, Inc.
0.4402
+1.55%
BCLI Brainstorm Cell Therapeutics Inc.
1.1100
-0.89%
PCSA Processa Pharmaceuticals, Inc.
0.2980
+1.88%
TVGN Tevogen Bio Holdings Inc.
1.2900
0.00%
MTNB Matinas BioPharma Holdings, Inc.
0.8200
+0.61%
SLXN Silexion Therapeutics Corp
0.9600
-7.69%
SPRC SciSparc Ltd.
0.3160
+0.70%
ENSC Ensysce Biosciences, Inc.
2.2200
0.00%
REVB Revelation Biosciences, Inc.
0.8230
-3.18%